Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
8.60
+0.26 (3.12%)
At close: May 12, 2025, 4:00 PM
8.74
+0.14 (1.63%)
After-hours: May 12, 2025, 6:25 PM EDT
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Bicycle Therapeutics stock have an average target of 25, with a low estimate of 14 and a high estimate of 48. The average target predicts an increase of 190.70% from the current stock price of 8.60.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bicycle Therapeutics stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 8 | 8 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +97.67% | May 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $32 | Buy | Maintains | $35 → $32 | +272.09% | May 2, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $17 → $14 | Hold | Maintains | $17 → $14 | +62.79% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $26 → $22 | Buy | Maintains | $26 → $22 | +155.81% | May 2, 2025 |
| Needham | Needham | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +237.21% | May 2, 2025 |
Financial Forecast
Revenue This Year
32.29M
from 35.28M
Decreased by -8.47%
Revenue Next Year
32.37M
from 32.29M
Increased by 0.27%
EPS This Year
-3.51
from -2.90
EPS Next Year
-4.18
from -3.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 63.0M | 75.6M | 225.8M | ||
| Avg | 32.3M | 32.4M | 98.7M | ||
| Low | n/a | n/a | 18.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 78.6% | 134.1% | 597.3% | ||
| Avg | -8.5% | 0.3% | 204.8% | ||
| Low | - | - | -44.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.92 | -3.43 | -2.84 | ||
| Avg | -3.51 | -4.18 | -3.58 | ||
| Low | -3.92 | -5.24 | -4.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.